United States · FDA National Drug Code directory
eteplirsen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61434-035_3c418de9-a70c-5616-e063-6394a90a1f22
- Product NDC
- 61434-035
- Form
- INJECTION
- Composition / generic term
- eteplirsen
- Labeler
- Catalent Indiana, LLC
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20160919
- Source listing expiry
- 20261231
Source-listed ingredients
- ETEPLIRSEN — 500 mg/10mL
These values do not establish equivalence or a dose recommendation.
Packages
- 288 VIAL in 1 CASE (61434-035-01) / 10 mL in 1 VIAL · 61434-035-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →